Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Find Radio Compass News for Aspirin

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

EU WC

EU WC

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
7
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • CAPSULE;ORAL - 356.4MG;30MG;16MG
  • TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE;ORAL - 325MG;50MG;40MG;30MG
  • TABLET, DELAYED RELEASE;ORAL - 325MG;40MG
  • TABLET, DELAYED RELEASE;ORAL - 81MG;40MG
  • TABLET;ORAL - 250MG;250MG;65MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - 325MG;50MG;40MG

https://www.evotec.com/en/news/bayer-and-evotec-collaborate-to-advance-precision-cardiology

PRESS RELEASE
30 Apr 2024

https://www.contractpharma.com/contents/view_breaking-news/2024-04-09/askbio-names-dr-mansuo-shannon-as-chief-scientific-officer/

CONTRACTPHARMA
09 Apr 2024

https://www.business-standard.com/markets/capital-market-news/dr-reddy-s-labs-partners-with-bayer-for-second-brand-of-vericiguat-for-india-market-124040600101_1.html

BUSINESS STANDARD
06 Apr 2024

https://www.fiercepharma.com/pharma/big-pharma-ceos-gather-beijing-continued-interest-china-policy-advice-local-drug-industry

Angus Liu FIERCE PHARMA
26 Mar 2024

https://www.biospectrumasia.com/news/105/23967/bayer-and-thermo-fisher-collaborate-to-increase-patient-access-to-precision-cancer-medicines.html

BIOSPECTRUM ASIA
20 Mar 2024

https://www.jnj.com/new-voyager-pad-analyses-reinforce-benefit-of-xarelto-rivaroxaban-plus-aspirin-across-high-risk-and-complex-patient-populations-with-peripheral-artery-disease-pad

PRESS RELEASE
14 Nov 2023

https://www.prnewswire.com/news-releases/bluerocks-phase-i-study-with-bemdaneprocel-in-patients-with-parkinsons-disease-meets-primary-endpoint-301910863.html

PR NEWSWIRE
28 Aug 2023

https://www.prnewswire.com/news-releases/novel-combination-of-oral-ketamine-and-aspirin-is-safe-form-of-pain-medication-after-total-knee-replacement-surgery-301902136.html

PR NEWSWIRE
16 Aug 2023

https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/now-you-will-need-a-prescription-for-buying-aspirin-ibrufin-diclofinac-in-delhi-read-why/articleshow/102003935.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMIC TIMES
21 Jul 2023

https://www.businesswire.com/news/home/20230622671663/en

BUSINESSWIRE
22 Jun 2023

https://www.businesswire.com/news/home/20230504006018/en

BUSINESSWIRE
04 May 2023

https://recalls-rappels.canada.ca/en/alert-recall/jamp-asa-ec-product-quality

HEALTH CANADA
20 Apr 2023

https://www.prnewswire.com/news-releases/new-voyager-pad-analysis-confirms-consistent-benefit-of-xarelto-rivaroxaban-plus-aspirin-following-lower-extremity-revascularization-ler-301762498.html

PR NEWSWIRE
05 Mar 2023

https://www.businesswire.com/news/home/20230206005102/en

BUSINESSWIRE
06 Feb 2023

http://www.pharmabiz.com/NewsDetails.aspx?aid=154306&sid=2

PHARMABIZ
07 Nov 2022

https://www.fiercepharma.com/marketing/plx-pharma-strikes-new-collab-baseball-legend-john-smoltz-take-its-pain-drug-vazalore

Ben Adams FIERCEPHARMA
20 Sep 2022

https://www.escardio.org/The-ESC/Press-Office/Press-releases/COVID-19-patients-in-the-community-do-not-benefit-from-colchicine-or-aspirin

ESCARDIO
29 Aug 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-27-2022-1659339221.pdf

FDA
27 Jul 2022

https://www.prnewswire.com/news-releases/new-data-from-two-large-studies-reinforce-effectiveness-of-dual-pathway-inhibition-dpi-with-xarelto-rivaroxaban-plus-aspirin-in-patients-with-coronary-artery-disease-cad-andor-peripheral-artery-disease-pad-301552796.html

PRNEWSWIRE
23 May 2022

https://www.prnewswire.com/news-releases/data-from-new-voyager-pad-analyses-at-acc22-reinforce-benefit-of